Seizing the Moment: Tackling Entrenched Inequalities to End Epidemics
Categories: Global Public Health, Human Rights, Humanitarian Emergencies
Sub-Categories: COVID-19, Economic Participation, Economic Recovery, Human Development, Sexual and Gender-Based Violence (SGBV), Sexual and Reproductive Health
Region: No Region
Year: 2020
Citation: "Seizing the Moment: Tackling Entrenched Inequalities to End Epidemics." The Joint United Nations Programme on HIV/AIDS. July 2020.
Sub-Categories: COVID-19, Economic Participation, Economic Recovery, Human Development, Sexual and Gender-Based Violence (SGBV), Sexual and Reproductive Health
Region: No Region
Year: 2020
Citation: "Seizing the Moment: Tackling Entrenched Inequalities to End Epidemics." The Joint United Nations Programme on HIV/AIDS. July 2020.
Executive Summary
A new report by UNAIDS shows remarkable, but highly unequal, progress, notably in expanding access to antiretroviral therapy. Because the achievements have not been shared equally within and between countries, the global HIV targets set for 2020 will not be reached. The report, Seizing the Moment, warns that even the gains made could be lost and progress further stalled if we fail to act. It highlights just how urgent it is for countries to double down and act with greater urgency to reach the millions still left behind.
Women and girls in sub-Saharan Africa continue to be the most affected and accounted for 59% of all new HIV infections in the region in 2019, with 4500 adolescent girls and young women between 15 and 24 years old becoming infected with HIV every week. Young women accounted for 24% of new HIV infections in 2019, despite making up only 10% of the population in sub-Saharan Africa.
To fight the colliding epidemics of HIV and COVID-19, UNAIDS and partners are leading a global call for a People’s Vaccine for COVID-19, which has been signed by more than 150 world leaders and experts demanding that all vaccines, treatments and tests be patent-free, mass produced and distributed fairly and free for all.